Application of the Western-based adjuvant online model to Korean colon cancer patients; a single institution experience
<p>Abstract</p> <p>Background</p> <p>Adjuvant Online (AOL) is web-accessible risk-assessment model that predicts the mortality and the benefits of adjuvant therapy (<url>http://www.newadjuvantonline.com</url>). AOL has never been validated for Asian colon ca...
Main Authors: | Jung Minkyu, Kim Geon Woo, Jung Inkyung, Ahn Joong Bae, Roh Jae Kyung, Rha Sun Young, Chung Hyun Cheol, Kim Nam Kyu, Kim Tae Il, Shin Sang Joon |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-10-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | http://www.biomedcentral.com/1471-2407/12/471 |
Similar Items
-
Adjuvant Chemotherapy for Stage III Colon Cancer
by: Julien Taieb, et al.
Published: (2020-09-01) -
The Optimal Duration of Adjuvant Chemotherapy in Colon Cancer
by: Maike Collienne, et al.
Published: (2020-09-01) -
Evaluation of the adverse effect profile of the adjuvant treatment in patients with stage II-III colon cancer
by: Kerim Çayır, et al.
Published: (2010-06-01) -
Validation of a quantitative 12-multigene expression assay (Oncotype DX® Colon Cancer Assay) in Korean patients with stage II colon cancer: implication of ethnic differences contributing to differences in gene expression
by: Jeong DH, et al.
Published: (2015-12-01) -
Adjuvant Chemotherapy for Stage II Colon Cancer
by: Sara Elena Rebuzzi, et al.
Published: (2020-09-01)